AMENDMENT #2 TO CREDIT AGREEMENTCredit Agreement • November 9th, 2016 • Kadmon Holdings, Inc. • Pharmaceutical preparations
Contract Type FiledNovember 9th, 2016 Company IndustryThis AMENDMENT #2 TO CREDIT AGREEMENT, dated as of November 4, 2016 (this “Second Amendment”), is made among KADMON PHARMACEUTICALS, LLC, a Pennsylvania limited liability company, (the “Borrower”), certain Affiliates of the Borrower listed on the signature pages hereof under the heading “GUARANTORS” (each a “Guarantor” and, collectively, the “Guarantors”), and the lenders listed on the signature pages hereof under the heading “LENDERS” (each a “Lender” and, collectively, the “Lenders”), with respect to the Credit Agreement referred to below.
THIRD WAIVER AGREEMENT TO CREDIT AGREEMENTThird Waiver Agreement • November 9th, 2016 • Kadmon Holdings, Inc. • Pharmaceutical preparations • New York
Contract Type FiledNovember 9th, 2016 Company Industry JurisdictionThis THIRD WAIVER AGREEMENT TO CREDIT AGREEMENT, dated as of September 29, 2016 (this “Agreement”), is entered into by and among Kadmon Pharmaceuticals, LLC, a Pennsylvania limited liability company (the “Borrower”), the guarantors party hereto and each of the lenders listed on the signature pages hereof under the heading “LENDERS”. Unless otherwise defined herein or the context otherwise requires, terms used in this Agreement, including its preamble and recitals, have the meanings provided in the Credit Agreement (defined below).